Investors & Media
The Medicines Company is a biopharmaceutical company driven by an overriding purpose—to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers.
Press Releases
27 May 2019The Medicines Company Presents Clinical Data Analyses for Inclisiran at 87th European Atherosclerosis Society Congress18 May 2019New Long-Term Data Show that Twice-a-Year Dosing with Inclisiran Results in Persistent Lowering of LDL Cholesterol with No Material Safety Observations Out to Three Years10 May 2019The Medicines Company to Host Investor Conference Call and Webcast During National Lipid Association’s 2019 Scientific Sessions
View AllEvents & Presentations
Upcoming Events
There are no upcoming events at this time. Please check back.
Recent Events
Date
Event Details